Biolife Solutions
BLFS
P/S ratio for Biolife Solutions (BLFS)
P/S ratio as of May 2024 (TTM): 5.53
According to Biolife Solutions 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.52686. At the end of 2023 the company had a P/S ratio of 5.11.
P/S ratio history for Biolife Solutions from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.11 | 6.18% |
| 2022 | 4.81 | -63.06% |
| 2021 | 13.0 | -52.03% |
| 2020 | 27.2 | 120.59% |
| 2019 | 12.3 | 8.93% |
| 2018 | 11.3 | 52.32% |
| 2017 | 7.42 | 194.37% |
| 2016 | 2.52 | -39.82% |
| 2015 | 4.19 | 30.84% |
| 2014 | 3.20 | -32.19% |
| 2013 | 4.72 | 12.85% |
| 2012 | 4.18 | 231.26% |
| 2011 | 1.26 | -31.41% |
| 2010 | 1.84 | -62.01% |
| 2009 | 4.85 | 206.77% |
| 2008 | 1.58 | -63.22% |
| 2007 | 4.30 | -42.04% |
| 2006 | 7.41 | 219.12% |
| 2005 | 2.32 | 30.27% |
| 2004 | 1.78 | -20.95% |
| 2003 | 2.26 | 19.42% |
| 2002 | 1.89 | -31.36% |
| 2001 | 2.75 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Celanese CE | 1.57 | -71.50% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | 3.90 | -29.50% | 🇺🇸 USA |
 Amyris AMRS | 0.0689 | -98.75% | 🇺🇸 USA |